Avivagen Inc V.VIV

Alternate Symbol(s): VIVXF

Healthcare

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

TSXV:VIV - Post by User

Avivagen Inc

<< Previous

Bullboard Posts

Next >>

Post by DrJayseron Oct 14, 2020 8:07am

95 Views

Post# 31712759

philippines is a growing market?

On 10/13/20-The Philippines continues to be an important and growing feed market for Avivagen, with an estimated annual feed production of 18.2 million metric tonnes for 2020, up dramatically from 11.75 million metric tonnes in 2016 (i).

02/28/19- UNAHCO is the exclusive distributor for Avivagen’s OxC-beta™ Livestock in the Philippines, where it is now registered for use in all food animal species. The Philippines is an important feed market, with an estimated annual feed production of 19 million metric tons for 2019, up dramatically from 11.75 million metric tons in 2016i.

<< Previous

Bullboard Posts

Next >>

As AI expands, where can investors look for strong growth?